Thousands of people are going to be given access to a ground-breaking drug which will help the nation live with covid. Paxlovid was shown to reduce the risk of hospitalisation or death by 88 per cent in trials.
The anti-viral drug has now been added to a national study which is looking to see how such medication works in a population where most adults are already vaccinated. It is the second such drug to be included in the PANORAMIC national study which is being run by the University of Oxford in close collaboration with GP hubs.
It is already available directly through the NHS to those whose immune systems mean they are at higher risk of serious illness who test positive for the virus. This includes those who are immunocompromised, cancer patients, or those with Down’s Syndrome.
